Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common stock
-
Shares outstanding
-
2,198,384
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
70,134
-
Shares change
-
-1,074
-
Total reported value, excl. options
-
$102,359
-
Value change
-
-$2,277
-
Number of buys
-
6
-
Number of sells
-
7
-
Price
-
$1.47
Institutional Holders of Alaunos Therapeutics, Inc. - Common stock (TCRT) as of Q1 2025
As of 31 Mar 2025 Alaunos Therapeutics, Inc. - Common stock (TCRT) had 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 70,134 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), MORGAN STANLEY, OSAIC HOLDINGS, INC., GROUP ONE TRADING LLC, WELLS FARGO & COMPANY/MN, and Steward Partners Investment Advisory, LLC.
This table shows 29 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.